[HTML][HTML] The impact of medication side effects on adherence and persistence to hormone therapy in breast cancer survivors: a qualitative systematic review and …
N Peddie, S Agnew, M Crawford, D Dixon… - The Breast, 2021 - Elsevier
Abstract Background Hormone Therapy (HT) reduces the risk of breast cancer recurrence
and mortality in women with breast cancer. Despite these clinical benefits, rates of HT non …
and mortality in women with breast cancer. Despite these clinical benefits, rates of HT non …
Breast cancer patients' experiences of adherence and persistence to oral endocrine therapy: a qualitative evidence synthesis
C Clancy, J Lynch, P OConnor, M Dowling - European Journal of Oncology …, 2020 - Elsevier
Purpose Adjuvant endocrine therapy (AET) significantly reduces the risk of breast cancer
recurrence and mortality in women with hormone receptor (HR+) breast cancer. Despite the …
recurrence and mortality in women with hormone receptor (HR+) breast cancer. Despite the …
How patients experience endocrine therapy for breast cancer: an online survey of side effects, adherence, and medical team support
MJ Berkowitz, CK Thompson, LT Zibecchi… - Journal of Cancer …, 2021 - Springer
Purpose Many patients with hormone receptor–positive (HR+) breast cancer do not adhere
to endocrine therapy (ET), and treatment-related side effects are often discussed by …
to endocrine therapy (ET), and treatment-related side effects are often discussed by …
Refining and optimising a behavioural intervention to support endocrine therapy adherence (ROSETA) in UK women with breast cancer: protocol for a pilot fractional …
Introduction Women with breast cancer who do not adhere to adjuvant endocrine therapy
(AET) have increased risks of mortality and recurrence. There are multiple barriers to AET …
(AET) have increased risks of mortality and recurrence. There are multiple barriers to AET …
Understanding adjuvant endocrine therapy persistence in breast Cancer survivors
Background Adjuvant endocrine therapy (AET) significantly decreases the risk of breast
cancer recurrence and mortality. Notwithstanding the demonstrated efficacy of AET, 31–73 …
cancer recurrence and mortality. Notwithstanding the demonstrated efficacy of AET, 31–73 …
Supporting adjuvant endocrine therapy adherence in women with breast cancer: the development of a complex behavioural intervention using Intervention Mapping …
Background Adjuvant endocrine therapy (AET) reduces the risk of breast cancer recurrence
and mortality. However, up to three-quarters of women with breast cancer do not take AET …
and mortality. However, up to three-quarters of women with breast cancer do not take AET …
Optimization of an information leaflet to influence medication beliefs in women with breast cancer: a randomized factorial experiment
Background Adherence to adjuvant endocrine therapy (AET) is low in women with breast
cancer. Negative beliefs about the necessity of AET and high concerns are barriers to …
cancer. Negative beliefs about the necessity of AET and high concerns are barriers to …
Breast cancer survivors' lived experience of adjuvant hormone therapy: a thematic analysis of medication side effects and their impact on adherence
M Ibrar, N Peddie, S Agnew, A Diserholt… - Frontiers in …, 2022 - frontiersin.org
Objectives Side effects from Hormone Therapy (HT) impact medication adherence in breast
cancer survivors. Understanding the most distressing HT side effects and their impacts may …
cancer survivors. Understanding the most distressing HT side effects and their impacts may …
Interventions to increase adherence to oral therapies in breast cancer patients: A systematic review based on the behavior change technique taxonomy
M Pezzolato, C Marzorati, L Lanzoni… - Psycho …, 2023 - Wiley Online Library
Objective High rates of non‐adherence to oral medications in breast cancer (BC) patients
have been reported. Here we provide an up‐to‐date systematic review of the interventions …
have been reported. Here we provide an up‐to‐date systematic review of the interventions …
Adherence trajectories of adjuvant endocrine therapy in the five years after its initiation among women with non-metastatic breast cancer: a cohort study using …
L Lambert-Côté, AD Bouhnik, MK Bendiane… - Breast Cancer Research …, 2020 - Springer
Purpose Despite the benefits of adjuvant endocrine therapy (AET) for reducing recurrence
and mortality risks after hormone-sensitive breast cancer, AET adherence is sub-optimal for …
and mortality risks after hormone-sensitive breast cancer, AET adherence is sub-optimal for …